Alyeska Investment Group’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,341,518
Closed -$23.4M 962
2020
Q4
$23.4M Sell
1,341,518
-766,381
-36% -$10.7M 0.36% 93
2020
Q3
$24.7M Buy
2,107,899
+220,168
+12% +$2.92M 0.41% 86
2020
Q2
$24.5M Buy
1,887,731
+436,087
+30% +$5.24M 0.38% 88
2020
Q1
$13.4M Buy
1,451,644
+152,144
+12% +$2.13M 0.27% 109
2019
Q4
$21.6M Sell
1,299,500
-502,148
-28% -$8.14M 0.29% 117
2019
Q3
$30M Buy
1,801,648
+151,802
+9% +$2.1M 0.44% 83
2019
Q2
$22.7M Buy
1,649,846
+928,998
+129% +$14.2M 0.3% 110
2019
Q1
$12.4M Sell
720,848
-597,417
-45% -$9.45M 0.17% 159
2018
Q4
$16.8M Sell
1,318,265
-282,279
-18% -$4.28M 0.25% 126
2018
Q3
$26M Sell
1,600,544
-13,671
-0.8% -$195K 0.29% 105
2018
Q2
$20.8M Buy
1,614,215
+52,159
+3% +$705K 0.19% 149
2018
Q1
$19.4M Buy
1,562,056
+161,153
+12% +$1.96M 0.17% 160
2017
Q4
$19.6M Buy
1,400,903
+45,374
+3% +$665K 0.16% 158
2017
Q3
$22.8M Buy
1,355,529
+413,904
+44% +$6.74M 0.18% 169
2017
Q2
$15.8M Sell
941,625
-10,844
-1% -$162K 0.14% 203
2017
Q1
$14.8M Buy
952,469
+83,504
+10% +$1.19M 0.12% 223
2016
Q4
$13M Buy
868,965
+12,087
+1% +$170K 0.11% 254
2016
Q3
$10.8M Buy
856,878
+39,187
+5% +$393K 0.1% 255
2016
Q2
$7.36M Buy
817,691
+16,590
+2% +$163K 0.07% 276
2016
Q1
$7.94M Buy
801,101
+10,235
+1% +$105K 0.07% 257
2015
Q4
$9.1M Sell
790,866
-118,465
-13% -$1.47M 0.1% 218
2015
Q3
$12.3M Buy
909,331
+43,305
+5% +$587K 0.15% 191
2015
Q2
$12M Buy
866,026
+14,029
+2% +$190K 0.16% 202
2015
Q1
$12M Buy
851,997
+502,722
+144% +$6.84M 0.18% 206
2014
Q4
$4.76M Buy
349,275
+18,363
+6% +$251K 0.08% 273
2014
Q3
$5.05M Sell
330,912
-15,650
-5% -$240K 0.12% 223
2014
Q2
$5.83M Buy
346,562
+16,129
+5% +$290K 0.16% 211
2014
Q1
$6.63M Sell
330,433
-130,652
-28% -$2.83M 0.24% 177
2013
Q4
$8.94M Buy
+461,085
New +$8.15M 0.42% 104